热门资讯> 正文
2025-11-07 05:43
Pliant Therapeutics (NASDAQ: PLRX) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.52) by 17.31 percent. This is a 54.74 percent increase over losses of $(0.95) per share from the same period last year.